World's Best Scientists 2026 revealed!
Xiao-Jun Huang

Xiao-Jun Huang

D-Index & Metrics

Microbiology

D-Index
85
Citations
29793
World Ranking
866
National Ranking
22

Medicine

D-Index
86
Citations
32975
World Ranking
13958
National Ranking
158

Overview

Xiao-Jun Huang is affiliated with Peking University in China and has contributed extensively to the field of medicine, with a strong focus on hematology. Their research portfolio comprises 1,126 publications, predominantly in hematology with 507 works, as well as substantial contributions to immunology, oncology, genetics, and public health.

The scientist's work revolves around several key topics, notably hematopoietic stem cell transplantation, acute myeloid leukemia research, and acute lymphoblastic leukemia research. Additional research interests include chronic myeloid leukemia treatments, immune cell function and interaction, T-cell and B-cell immunology, and chronic lymphocytic leukemia research.

Over their career, Xiao-Jun Huang has published frequently in several scientific journals and publication venues, with the most prolific appearances in:

  • Blood (44 publications)
  • PubMed (42 publications)
  • Bone Marrow Transplantation (36 publications)
  • Annals of Hematology (21 publications)
  • British Journal of Haematology (19 publications)

Notable recent papers by the scientist include:

  • "Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial" (2020) published in The Lancet Oncology
  • "The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update" (2021) published in Journal of Hematology & Oncology
  • "Treatment and unmet needs in steroid-refractory acute graft-versus-host disease" (2020) published in Leukemia
  • "Naturally Selected CD7 CAR-T Therapy without Genetic Manipulations for T-ALL/LBL: First-in-human Phase I Clinical Trial" (2022) published in Blood
  • "Antithymocyte Globulin for Matched Sibling Donor Transplantation in Patients With Hematologic Malignancies: A Multicenter, Open-Label, Randomized Controlled Study" (2020) published in Journal of Clinical Oncology

The scientist collaborates frequently with other researchers, including Lan-Ping Xu, Yu Wang, Xiaohui Zhang, Kai-Yan Liu, and Xiao-Dong Mo, each with numerous joint publications.

Best Publications

  • The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts

    Camille Abboud;Ellin Berman;Adam Cohen

  • Manganese Increases the Sensitivity of the cGAS-STING Pathway for Double-Stranded DNA and Is Required for the Host Defense against DNA Viruses

    Chenguang Wang;Yukun Guan;Mengze Lv;Rui Zhang

  • Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation.

    Dao Pei Lu;Lujia Dong;Lujia Dong;Tong Wu;Tong Wu;Xiao Jun Huang;Xiao Jun Huang

  • Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study.

    Yu Wang;Qi-Fa Liu;Lan-Ping Xu;Kai-Yan Liu

  • Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies

    Huang Xj;Liu Dh;Liu Ky;Xu Lp

  • Who is the best donor for a related HLA haplotype-mismatched transplant?

    Yu Wang;Ying-Jun Chang;Lan-Ping Xu;Kai-Yan Liu

  • Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation

    Xiao-Jun Huang;Dai-Hong Liu;Kai-Yan Liu;Lan-Ping Xu

  • MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trial

    Hong-Hu Zhu;Xiao-Hui Zhang;Ya-Zhen Qin;Dai-Hong Liu

  • Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation

    Chen-Hua Yan;Dai-Hong Liu;Kai-Yan Liu;Lan-Ping Xu

  • The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China—recommendations from the Chinese Society of Hematology

    Lanping Xu;Hu Chen;Jing Chen;Mingzhe Han

  • Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial.

    Li Xuan;Yu Wang;Fen Huang;Zhiping Fan

  • Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia: nine years of experience at a single center.

    Yu Wang;Dai-Hong Liu;Kai-Yan Liu;Lan-Ping Xu

  • A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value.

    Wen-Lian Chen;Wen-Lian Chen;Jing-Han Wang;Ai-Hua Zhao;Xin Xu

  • Apoptotic Caspases Suppress Type I Interferon Production via the Cleavage of cGAS, MAVS, and IRF3

    Xiaohan Ning;Yutao Wang;Yutao Wang;Miao Jing;Miao Jing;Mengyin Sha;Mengyin Sha

  • The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update.

    Xiao-hui Zhang;Jing Chen;Ming-Zhe Han;He Huang

  • The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation.

    Stefan O. Ciurea;Kai Cao;Marcelo Fernadez-Vina;Piyanuch Kongtim

  • Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets.

    Ying-Jun Chang;Xiang-Yu Zhao;Lan-Ping Xu;Xiao-Hui Zhang

  • CD34+CD38+CD19+ as well as CD34+CD38−CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL

    Y Kong;S Yoshida;Y Saito;T Doi

  • Oral Tetra-Arsenic Tetra-Sulfide Formula Versus Intravenous Arsenic Trioxide As First-Line Treatment of Acute Promyelocytic Leukemia: A Multicenter Randomized Controlled Trial

    Hong-Hu Zhu;De-Pei Wu;Jie Jin;Jian-Yong Li

  • Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant.

    Lan-Ping Xu;Song Jin;Shun-Qing Wang;Ling-Hui Xia

  • Donor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched/haploidentical T-cell-replete hematopoietic stem cell transplantation.

    Xiao-Jun Huang;Dai-Hong Liu;Kai-Yan Liu;Lan-Ping Xu

Frequent Co-Authors

Hao Jiang
Hao Jiang East China University of Science and Technology
He Huang
He Huang Zhejiang University
Arnon Nagler
Arnon Nagler Sheba Medical Center
Zhengfan Jiang
Zhengfan Jiang Peking University
Yangyuan Wang
Yangyuan Wang Peking University
Myriam Labopin
Myriam Labopin Université Paris Cité
Jing Wang
Jing Wang Chinese Academy of Sciences
Fabio Ciceri
Fabio Ciceri Vita-Salute San Raffaele University
Bipin N. Savani
Bipin N. Savani Vanderbilt University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to diverse career pathways, many of which intersect with the healthcare and information management fields. For those interested in the business side of healthcare, pursuing certifications like certified professional coder salary can provide a solid foundation in medical coding, an essential skill in managing patient data and billing processes.

Advanced degrees, such as a master in health information management salary, offer specialized knowledge and leadership opportunities in managing health data systems. These roles are increasingly vital as healthcare moves towards digital record-keeping and data analytics.

For students seeking flexible educational options, accredited programs such as online health information management degree programs cahiim accredited provide recognized credentials that meet industry standards. These programs ensure students gain relevant skills while balancing other commitments.

Additionally, quick entry into the field is possible through fast online medical billing and coding certification programs, which prepare students for certification exams and immediate employment in medical administrative roles. Combining microbiology studies with skills in health information management or medical coding can create a well-rounded career profile in the expanding healthcare sector.

Best Scientists Citing Xiao-Jun Huang

Trending Scientists